Clinical trials
Terminated Recurrence trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 5 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 6 |
| University Health Network, Toronto | 4 |
| Amgen | 2 |
| British Columbia Cancer Agency | 2 |
| National Cancer Institute (NCI) | 2 |
| Pfizer | 2 |
| AHS Cancer Control Alberta | 1 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Cleave Biosciences, Inc. | 1 |
| Clovis Oncology, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 36 |
| Multiple Myeloma | 10 |
| Leukemia, Myeloid, Acute | 5 |
| Neoplasm Metastasis | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Leukemia | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Lymphoma, Non-Hodgkin | 3 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.